Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDCA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ABCF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOPORS-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
C21orf91 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRADC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIF1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZADH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DERL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNHG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBALD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHBDD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB11FIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THUMPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TEX264 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on